Furthermore, we have demonstrated the suppressing effects of EGFL8 on HCC cell metastasis, invasion and survival through regulating the Notch signaling pathway, indicating EGFL8 as a novel therapeutic target and a potential prognostic marker for HCC. This evidence concerns the gene EGFL8 and hepatocellular carcinoma.